Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 27.
doi: 10.1111/bju.70092. Online ahead of print.

The LaserSAFE technique for margin assessment during radical prostatectomy: a feasibility study

Ricardo Almeida-Magana  1   2 , Larissa Sena Teixeira Mendes  1   3 , Eoin Dinneen  1   2   4 , Tarek Al-Hammouri  5   2 , Aiman Haider  3 , Anna Silvanto  3 , Alex Freeman  3 , Nicholas Roberts  1   5 , Louise Dickinson  6 , Chun Wah So  6 , Zafer Tandogdu  2 , Benjamin W Lamb  2   7   8 , Nikhil Mayor  9   10 , Mathias Winkler  9   10 , Hashim Ahmed  9   10 , Greg Shaw  1   2
Affiliations

The LaserSAFE technique for margin assessment during radical prostatectomy: a feasibility study

Ricardo Almeida-Magana et al. BJU Int. .

Abstract

Objectives: To assess the feasibility of conducting a multicentre trial comparing NeuroSAFE with a novel technique based on confocal laser microscopy (LaserSAFE) and evaluate the diagnostic performance of LaserSAFE for real-time surgical margin assessment.

Patients and methods: This was a non-randomised, prospective feasibility study conducted at a high-volume academic UK centre (ClinicalTrials.gov identifier: NCT06398470). Patients with localised prostate cancer (clinical T2-T3a N0 M0) scheduled for robot-assisted radical prostatectomy and deemed unsuitable for bilateral intrafascial nerve sparing (NS) based on a multidisciplinary plan were included. LaserSAFE imaging was performed in the operating room after which the NeuroSAFE technique results guided NS decisions. Pathologists, blinded to NeuroSAFE and final histology, retrospectively evaluated LaserSAFE images. Diagnostic accuracy metrics and concordance between modalities were calculated. Feasibility was assessed based on recruitment rate and the ability to activate additional sites.

Results: A total of 20 patients were recruited at a single site within 12 months of recruitment start. However, expansion to additional centres was not feasible due to limitations in implementing the NeuroSAFE protocol. LaserSAFE achieved a sensitivity of 0.91 (95% confidence interval [CI] 0.59-1.00) and specificity of 1.00 (95% CI 0.88-1.00) for detecting positive surgical margins ≥0.5 mm. Cohen's kappa demonstrated strong agreement with NeuroSAFE and final pathology. LaserSAFE was completed within a median of 7 min, significantly shorter than the 63 min required for NeuroSAFE. Limitations include the small sample size, single-centre setting, and lack of intraoperative decision-making based on LaserSAFE findings.

Conclusion: While a multicentre study based on NeuroSAFE as a comparison was not achievable, LaserSAFE proved to be a rapid and accurate alternative for intraoperative margin assessment. These findings support the design of a larger trial in which NS decisions are informed by LaserSAFE, with a view to broadening access to real-time margin assessment.

Keywords: feasibility study; fluorescence confocal microscopy; intraoperative margin assessment; prostate cancer; radical prostatectomy.

PubMed Disclaimer

References

    1. Walz J, Epstein JI, Ganzer R et al. A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimisation of cancer control and preservation of continence and erection in candidates for radical prostatectomy: an update. Eur Urol 2016; 70: 301–311
    1. Heesakkers J, Farag F, Bauer RM, Sandhu J, De Ridder D, Stenzl A. Pathophysiology and contributing factors in postprostatectomy incontinence: a review. Eur Urol 2017; 71: 936–944
    1. Donovan JL, Hamdy FC, Lane JA et al. Patient‐reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 2016; 375: 1425–1437
    1. James ND, Tannock I, N'Dow J et al. The lancet commission on prostate cancer: planning for the surge in cases. Lancet 2024; 403: 1683–1722
    1. Nguyen LN, Head L, Witiuk K et al. The risks and benefits of cavernous neurovascular bundle sparing during radical prostatectomy: a systematic review and meta‐analysis. J Urol 2017; 198: 760–769

Associated data

LinkOut - more resources